Product How it works Pricing Blog FAQ About Contact
Caribou Biosciences

Caribou Biosciences (NASDAQ: CRBU) revenue

Caribou Biosciences reported revenue of $11.2m for fiscal 2025, 11.7% more than in fiscal 2024 ($10.0m). Since fiscal 2020 its revenue has fallen by 9.7%, an average decline of 2.0% a year.

Caribou Biosciences's best year of the last 6 was fiscal 2023. The biggest drop was in fiscal 2024, −71.0%.

Revenue, in millions of US dollars12.420209.6202113.9202234.5202310.0202411.22025
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Revenue by fiscal year

Fiscal yearRevenueChangeOperating profitOperating margin
2025$11.2m+11.7%−$148.3m−1,329.4%
2024$10.0m−71.0%−$166.6m−1,667.2%
2023$34.5m+148.9%−$116.1m−336.6%
2022$13.9m+44.3%−$106.4m−768.2%
2021$9.6m−22.4%−$67.0m−697.8%
2020$12.4m—−$36.1m−292.2%

The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

Caribou Biosciences revenue compared with its sector

By revenue for its latest fiscal year, Caribou Biosciences ranks 365th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Caribou Biosciences, 11.7%.

RankCompanyRevenueRevenue growth
363rdTonix Pharmaceuticals$13.1m29.8%
364thPrelude Therapeutics$12.1m73.4%
365thCaribou Biosciences$11.2m11.7%
366thCrescent Biopharma$10.8m—
367thJanux Therapeutics$10.0m−5.6%

Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.

Questions about the revenue of Caribou Biosciences

How much revenue did Caribou Biosciences make in fiscal 2025?
Caribou Biosciences reported revenue of $11.2m for fiscal 2025, compared with $10.0m in fiscal 2024.
How much has the revenue of Caribou Biosciences fallen?
Between fiscal 2020 and fiscal 2025 it went from $12.4m to $11.2m: 9.7% less, an average decline of 2.0% a year.
What was the best year for revenue at Caribou Biosciences?
Of its last 6 fiscal years, fiscal 2023, with $34.5m.
Where does Caribou Biosciences rank in its sector by revenue?
It ranks 365th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
Where do the figures for Caribou Biosciences come from?
From the annual report (Form 10-K) that Caribou Biosciences files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that Caribou Biosciences files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020. More on Caribou Biosciences: the Caribou Biosciences page · annual accounts · net income · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.